Kestra Insiders Sell 11,061 Shares as $1.41B Medtech Posts -138% Margin
Two Kestra Medical Technologies insiders disclosed routine tax-withholding sales totaling 11,061 shares after a July earnings report that missed consensus. The transactions highlight equity-vesting mechanics, but the company's negative margins and projected losses are a more consequential signal for healthcare partners assessing vendor sustainability.
Source: dailypolitical.com · tickerreport.com